Healthcare Equipment and Supplies
Company Overview of 20/20 GeneSystems, Inc.
20/20 GeneSystems, Inc. develops and commercializes tests that aid in the early detection and therapy selection of cancer diseases. It offers proteomics products that provide tools for protein analysis; PredicTOR, a companion diagnostic test, as well as offers L-IHC tissue analysis for multiplex biomarker analysis; and protein assay utilizing lung cancer analytes test, a blood test for the early detection of lung cancer. The company also engages in licensing its solutions. It serves drug companies, biodefense specialists, and life scientists in the United States. 20/20 GeneSystems, Inc. was founded in 2000 and is headquartered in Rockville, Maryland.
9430 Key West Avenue
Rockville, MD 20850
Founded in 2000
Key Executives for 20/20 GeneSystems, Inc.
20/20 GeneSystems, Inc. Key Developments
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
January 28, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact 20/20 GeneSystems, Inc., please visit 2020gene.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.